LB-004 - BETWEEN-ASSAY VARIABILITY MIGHT EXPLAIN DIFFERENCES IN PROPOSED Z-ENDOXIFEN EFFICACY THRESHOLDS – EXPLORATORY ANALYSIS RESULTS OF THE CYP2D6 PERCENTAGE ACTIVITY ENDOXIFEN MODEL IN BREAST CANCER (CEPAM) CONSORTIUM DATABASE.
A. Mc Laughlin1,2, T. Helland3,4,5, R. Michelet1, G. Mikus1, D. Hertz3, C. Kloft1; 1Freie Universität Berlin, Berlin, Germany, 2PharMetrX, Berlin, Germany, 3University of Michigan, Ann Arbor, MI, USA, 4Haukeland University Hospital, Bergen, Norway, 5University of Bergen, Bergen, Norway.